Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Rational Design of Magnetic Nanoparticles for Cochlear Drug Delivery

Award Number: K08DC020780
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 08/01/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2028

Group Awards By:

View Award Description

Rational Design of Magnetic Nanoparticles for Cochlear Drug Delivery - Abstract I am a neurotologist and assistant professor in the department of Otolaryngology-Head and Neck Surgery at the Johns Hopkins University School of Medicine. I am applying for a K08 mentored surgeon-scientist career development award (CDA) to obtain further training related to chemical engineering-based approaches to improving drug delivery in the ear for treatment of hearing loss. Specifically, I am interested in developing magnetic nanoparticles as a novel drug delivery platform in the treatment of hearing loss. My long-term career goals are to lead the translational development of novel drug delivery technologies that can enable the safe and effective delivery of emerging pharmaceutics into the inner ear. Despite rapid emergence of promising therapeutics such as protein-based neuronal growth factors and gene therapies for various forms of sensorineural hearing loss, their clinical translation is limited by the lack of a delivery vehicle that can be administered in a minimally-invasive and redoseable fashion in the clinic. Magnetic nanoparticles have unique chemical and physical properties that may be well suited as a cochlear delivery vehicle for macromolecular pharmaceutics. Their polymeric coating has payload capacity for proteins and DNA, while their superparamagnetic iron oxide nanocores can move in a magnetic field gradient, allowing for magnetically-assisted delivery across the round window membrane and into perilymph. However, rational design of magnetic nanoparticles for cochlear drug delivery requires an understanding of how nanoparticle properties relate to transport and pharmacokinetic behavior in the cochlea. This CDA proposes leveraging my previous experience in translational engineering research of the inner ear to elucidate how chemical and physical properties of custom-synthesized magnetic nanoparticles affect their consequent transport properties as cochlear drug delivery vehicles in vitro and in vivo. Specific training goals include: 1) training in nanoparticle science and drug delivery, 2) training in the guinea pig pharmacokinetic model, and 3) training in immunohistologic and histologic assays of the temporal bone, 4) training in ethical conduct of research, and 5) development of skills, techniques, and preliminary data that will lead to submission of a successful R01 application. The research plan investigates the hypothesis that nanoparticle size is an important mediator of magnetic nanoparticle transport in the cochlea and performance as a drug delivery vehicle. Using a guinea pig model validated for the study of perilymph pharmacokinetics of applied drugs, the specific aims of the proposal are to understand the impact of nanoparticle size on 1) transport across round window membrane explants in vitro, 2) perilymph concentration profiles and biodistribution in cochlear tissues in vivo, and 3) ability to deliver brain- derived neurotrophic factor into cochlear perilymph in vivo.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $200,122 )
2026	2026	CINCINNATI UNIV OF	2600 CLIFTON AVE	CINCINNATI	OH	45220	HAMILTON	USA	Research Related to Deafness and Communication Disorders	000	4	1/21/2026	NON-COMPETING CONTINUATION	$200,122
														Subtotal = $200,122

Issue Date FY: 2025 ( Subtotal = $200,506 )
2025	2025	CINCINNATI UNIV OF	2600 CLIFTON AVE	CINCINNATI	OH	45220	HAMILTON	USA	Research Related to Deafness and Communication Disorders	000	3	12/18/2024	NON-COMPETING CONTINUATION	$200,506
														Subtotal = $200,506

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2024	UNIVERSITY OF CINCINNATI	2600 CLIFTON AVE	CINCINNATI	OH	45220	HAMILTON	USA	Research Related to Deafness and Communication Disorders	001	2	1/11/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$200,880
2024	2023	THE JOHNS HOPKINS UNIVERSITY	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	1	1/11/2024	NEW	-$200,880
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $200,880 )
2023	2023	JOHNS HOPKINS UNIVERSITY, THE	3400 N CHARLES ST	BALTIMORE	MD	21218	BALTIMORE CITY	USA	Research Related to Deafness and Communication Disorders	000	1	7/19/2023	NEW	$200,880
														Subtotal = $200,880

Grand Total All Awards = $601,508

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rational Design of Magnetic Nanoparticles for Cochlear Drug Delivery

Award Number: K08DC020780

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 08/01/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer